GenMark Diagnostics, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Operating activities
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Depreciation and amortization
Net amortization (accretion) of premiums/discounts on investments
Gain on sale of investment in preferred stock
Net accretion of premiums/discounts on investments
Amortization of deferred debt issuance costs
Stock-based compensation
Provision for bad debt, net of recoveries
Non-cash inventory adjustments
Other non-cash adjustments
Changes in operating assets and liabilities
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable
Accrued compensation
Operating lease right-of-use assets and lease liabilities
Other current and non-current liabilities
Net cash provided by (used in) operating activities
Investing activities
Payments for intellectual property licenses
Purchases of property and equipment
Purchases of marketable securities
Proceeds from sales of marketable securities
Maturities of marketable securities
Net cash provided by (used in) investing activities
Financing activities
Proceeds from issuance of common stock, net of offering costs
Costs incurred in conjunction with public offering
Principal repayment of borrowings
Proceeds from borrowings
Payments associated with debt issuance
Proceeds from stock option exercises
Net cash provided by financing activities
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of year
Cash, cash equivalents, and restricted cash at end of year
Non-cash investing and financing activities
Transfer of systems from property and equipment into inventory
Intellectual property acquisition included in accrued expenses
Transfer of systems to property and equipment from inventory
Property and equipment included in accounts payable
Right-of-use assets obtained in exchange for new operating lease liabilities

Supplemental cash flow information
Cash received for interest
Cash paid for interest, net
Cash paid for income taxes, net

Comments